Hikma Pharmaceuticals
1978
FOUNDED
PUBLIC
STATUS
5K-10K
EMPLOYEES
HIK
STOCK SYMBOL
19
INVESTMENTS
$24.58
SHARE PRICE
(As of Wednesday Closing)
Description
Founded in the Middle East and with headquarters in London, Hikma manufactures generic and in-licensed pharmaceuticals. The firm operates in three segments: injectables, generics, branded, and other, which comprise most of the company's revenue at about 40%, 33%, and 26%, respectively. About 63%, 32%, and 6% of Hikma's sales are based in the U.S., Middle East, North Africa, and Europe, and Other.
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
LON
Primary Office
- 1 New Burlington Place
- London W1S 2HR
- England, United Kingdom
+44 020 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Hikma Pharmaceuticals’s full profile, request a free trial.
Hikma Pharmaceuticals Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $19.63 - $27.26 | $5.96B | $24.67 | $1.49 | 609K | 242M |
Hikma Pharmaceuticals Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 5,638,341 | 5,750,556 | 4,294,666 | 6,399,338 |
| Revenue | 2,138,000 | 2,070,000 | 1,936,000 | 1,950,000 |
| EBITDA | 505,000 | 440,000 | (553,000) | 368,000 |
| Net Income | 361,000 | 282,000 | (843,000) | 155,000 |
| Total Assets | 3,606,000 | 3,497,000 | 3,388,000 | 4,363,000 |
| Total Debt | 695,000 | 637,000 | 777,000 | 860,000 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Hikma Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Hikma Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookHikma Pharmaceuticals Competitors (4)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mylan | Corporation | Hatfield, United Kingdom | 00000 | 00.00 | 000000&0 | 00.00 |
| 000000 00000000000 | Corporation | Tokyo, Japan | 00000 | 0000 | ||
| 000 00000000000000 | Corporation | Mumbai, India | 00000 | 00000000000 | ||
| 000000 | Corporation | Carros, France | 0000 |
Hikma Pharmaceuticals Investments & Acquisitions (19)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 (000 | 08-Nov-2018 | 000000000000000000 | Medical Supplies | 0000 000000000 | |
| 000000 00000000000 | 29-Feb-2016 | 000000000000000000 | 00.000 | Pharmaceuticals | 0000 00000000 |
| 0000 000000 000000 | 17-Feb-2016 | 000000000000000000 | 000.00 | Drug Discovery | |
| 000000000000000 00 | 17-Sep-2014 | 000000000 00000 00 | Buildings and Property | 0000 00000000 | |
| Bedford Laboratories | 15-Jul-2014 | Merger/Acquisition | 00000 | Medical Supplies | 0000 00000000 |
Hikma Pharmaceuticals Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000000000 00 | 17-Sep-2014 | 000000000 00000 00 | Completed |
|
|
| 000 00000 00000000 | 15-Jul-2014 | 000000000000000000 | 00000 | Completed |
|
| Unimark Remedies | 16-May-2011 | Corporate | 000.00 | Completed |
Hikma Pharmaceuticals Subsidiaries (5)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Hikma Ventures | Corporate Venture Capital | London, United Kingdom | 2015 |
| 0000 000000 000000 | Drug Discovery | Cairo, Egypt | 0000 |
| 00000000000 | Distributors (Healthcare) | Gräfelfing, Germany | 0000 |
| 0000 0000000000000 | Acquirer | Al Salt, Jordan | 0000 |
| 0000000000 | Pharmaceuticals | Casablanca, Morocco | 0000 |
Hikma Pharmaceuticals Executive Team (25)
5 Former Executives
You’re viewing 5 of 25 executives. Get the full list »Hikma Pharmaceuticals Board Members (11)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 000 00-00000 | Self | Board Member | 000 0000 | |
| 000000 0000 | Self | Board Member | 000 0000 | |
| 0000 0000000000 | Hikma Pharmaceuticals | Board Member | 000 0000 | |
| 00000 00000 00000 00000000 | Hikma Pharmaceuticals | Executive Vice Chairman, President and Chief Executive of MENA and Emerging Markets | 000 0000 | |
| 0000 000000000 | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 11 board members. Get the full list »